Clinical application of cell‐based therapies opportunities and challenges

Immune checkpoint inhibitors or anti-cancer immunotherapy using cellular transfer have emerged as new therapies in this field. These work to overcome alleviate tumour-induced immunosuppression, resulting immune-mediated tumour clearance. Cellular the largest number of active agents and clinical trials. More targets been explored, more trials opened patients recruited for a result recent advancements. In article, we describe latest developments major obstacles cell therapy cancer treatment, starting with tumour-infiltrating T cells.